Mohane Selvaraj Coumar

Employment

• Pondicherry University Assistant Professor
  2010 - Present
• National Health Research Institutes Post Doctoral Fellow
  2004 - 2010
• Ranbaxy Laboratories Ltd Research Scientist
  2002 - 2003

Education

• Panjab University Ph.D
  1997 - 2001
• Panjab University M. Pharm
  1994 - 1996
• Medical College Thiruvananthapuram B.Pharm
  1989 - 1994

Projects & Funding

Projects & funding information is unavailable.

Publications (86)

• Cheminformatics analysis, machine learning-based QSAR model building and virtual screening: identification of dual ROCK1 and TGFBR1 inhibitors for the treatment of cancer metastasis
  Journal of Molecular Graphics and Modelling 2026 DOI: 10.1016/j.jmgm.2026.109428
  +Save
• Identification of dual inhibitors of ROCK1 and TGFBR1 for overcoming metastasis: an integrated pharmacophore and docking driven CADD strategy
  In Silico Pharmacology 2025 DOI: 10.1007/s40203-025-00414-5
  +Save
• Exploring imidazo[4,5- g ]quinoline-4,9-dione derivatives as Acinetobacter baumannii efflux pump inhibitor: an in silico approach
  Journal of Biomolecular Structure and Dynamics 2025 DOI: 10.1080/07391102.2023.2279287
  +Save
• Unveiling the potential of a novel drug efflux pump inhibitor to combat multidrug resistance in ESKAPEE pathogens, with a focus on Acinetobacter baumannii
  Microbial Pathogenesis 2025 DOI: 10.1016/j.micpath.2025.107513
  +Save
• Deciphering Breast Cancer Metastasis Cascade: A Systems Biology Approach Integrating Transcriptome and Interactome Insights for Target Discovery
  OMICS: A Journal of Integrative Biology 2024 DOI: 10.1089/omi.2023.0285
  +Save
• WITHDRAWN: Revealing the neuroprotection and neurodegeneration efficacy of marine sponge extract in Parkinson's disease using gene expression and molecular docking
  Biochemical and Biophysical Research Communications 2023 DOI: 10.1016/j.bbrc.2023.05.003
  +Save
• Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer
  Journal of Medicinal Chemistry 2023 DOI: 10.1021/acs.jmedchem.2c01434
  +Save
• Bacterial effluxome as a barrier against antimicrobial agents: structural biology aspects and drug targeting
  Tissue Barriers 2022 DOI: 10.1080/21688370.2021.2013695
  +Save
• Survivin - caspase protein-protein interaction: Experimental evidence and computational investigations to decipher the hotspot residues for drug targeting
  Journal of Molecular Structure 2021 DOI: 10.1016/j.molstruc.2020.129619
  +Save
• Overcoming vincristine resistance in cancer: Computational design and discovery of piperine‐inspired P‐glycoprotein inhibitors
  Chemical Biology & Drug Design 2021 DOI: 10.1111/cbdd.13758
  +Save